Acerca de
Dr Panagiotis Koliou is a highly experienced Consultant Medical Oncologist with over 17 years of clinical practice, specialising in the management of early and advanced breast cancer. He is recognised for delivering personalised, evidence-based care, combining the latest advances in oncology with a compassionate, patient-centred approach.
His expertise spans the full range of systemic anticancer treatments, including endocrine therapy, chemotherapy, antibody–drug conjugates, targeted therapies and immunotherapy. Dr Koliou treats patients across both standard care pathways and cutting-edge clinical trials, ensuring access to the most innovative therapies available.
Dr Koliou graduated in Medicine from the University of Ioannina and holds an honours degree in Biochemistry from Benedictine University, USA. He completed a Master’s degree in Clinical Biochemistry and Molecular Biology at the University of Surrey and was awarded a PhD in Medical Oncology with First Class honours from University of Ioannina, Greece. He undertook specialist training in Medical Oncology at the Aristotle University of Thessaloniki in Greece and at University College London Hospital.
He has a strong interest in precision oncology, using advanced molecular and genomic profiling to tailor treatments to each individual patient. His work incorporates the use of circulating tumour DNA and other liquid biopsy technologies to guide treatment decisions and monitor disease in real time.
Dr Koliou has extensive experience in managing complex metastatic breast cancer, with particular expertise in sequencing therapies and optimising outcomes across multiple lines of treatment. He is also an active contributor to research and innovation, having served as Principal Investigator in multiple Phase III clinical trials in breast cancer and melanoma at Royal Surrey, helping to bring forward new standards of care.
Known for his clarity, attention to detail and commitment to excellence, Dr Koliou works closely with multidisciplinary teams to ensure each patient receives the highest standard of care throughout their treatment journey.
His expertise spans the full range of systemic anticancer treatments, including endocrine therapy, chemotherapy, antibody–drug conjugates, targeted therapies and immunotherapy. Dr Koliou treats patients across both standard care pathways and cutting-edge clinical trials, ensuring access to the most innovative therapies available.
Dr Koliou graduated in Medicine from the University of Ioannina and holds an honours degree in Biochemistry from Benedictine University, USA. He completed a Master’s degree in Clinical Biochemistry and Molecular Biology at the University of Surrey and was awarded a PhD in Medical Oncology with First Class honours from University of Ioannina, Greece. He undertook specialist training in Medical Oncology at the Aristotle University of Thessaloniki in Greece and at University College London Hospital.
He has a strong interest in precision oncology, using advanced molecular and genomic profiling to tailor treatments to each individual patient. His work incorporates the use of circulating tumour DNA and other liquid biopsy technologies to guide treatment decisions and monitor disease in real time.
Dr Koliou has extensive experience in managing complex metastatic breast cancer, with particular expertise in sequencing therapies and optimising outcomes across multiple lines of treatment. He is also an active contributor to research and innovation, having served as Principal Investigator in multiple Phase III clinical trials in breast cancer and melanoma at Royal Surrey, helping to bring forward new standards of care.
Known for his clarity, attention to detail and commitment to excellence, Dr Koliou works closely with multidisciplinary teams to ensure each patient receives the highest standard of care throughout their treatment journey.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Panagiotis Koliou
Educación y formación
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Oncología
Carrera y nombramientos
-
2027-09–2028-08 Junior consultant
Licencias y seguros
Licencias médicas
GB — Organización Médica Colegial de España (OMC)
Certificaciones del consejo
European Board of Oncología
Seguro de responsabilidad profesional:
Generali Healthcare · 5,000,000 EUR cobertura · No claims on file
Procedimientos realizados
| Procedimiento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 1,257 |
| Annual physical exam | 99395 | 2,071 |
| Vaccination administration | 90471 | 207 |
| Minor procedure (skin) | 17110 | 1,152 |
Servicios y precios
| Servicio | Duración | Modalidad | Precio |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 720.00 EUR |
Consulta, equipo y en práctica
Vídeos
Investigación y publicaciones
índice h: 16 · i10: 7
-
Validation of clinical scoring in Oncología
DOI: 10.8522/euroclin.2026.0 · PMID: 31811256 · citado por 17
-
Long-term follow-up of Oncología across GB
DOI: 10.8605/euroclin.2025.1 · PMID: 35432255 · citado por 51
-
Validation of clinical scoring in Oncología
DOI: 10.8463/euroclin.2024.2 · PMID: 38956036 · citado por 29
Conferencias invitadas
- Practical updates in Oncología European Annual Congress (Oncología) · Vienna · 2024 · invited
- Single-centre experience in Oncología National Society Meeting · Guildford · 2023 · oral abstract
Premios y afiliaciones
Premios
- 🏆 Top-rated Oncología — Guildford · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Membresías en sociedades
- WONCA Europe — Family Doctors — Member · Desde 2028
- national college of family doctors — Member · Desde 2028
- European Union of Medical Specialists (UEMS) — Member · Desde 2028
Artículos de este doctor
- Patient education Patient guide to Oncología
- Awareness When should you see a oncología?
Para pacientes internacionales
- Coordinador
- Patient liaison · panagiotis.koliou@euroclinics.example
- Seguros internacionales aceptados
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Ubicación
1 etiquetaReseñas de pacientes
18 reseñas verificadas5.00
★★★★★
18 reseñas
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Comparta su experiencia — ayude a otros pacientes a encontrar el médico adecuado. Escribir una reseña →
Reseñas recientes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Especialistas similares
Ver todos →
Mr Abdulla Alhasso
Oncología · Glasgow
Dr Alexander McDonald
Oncología · Glasgow
Dr Amna Sheri
Oncología · London
Dr Angus Robinson
Oncología · Horley
Dr Anne Armstrong
Oncología · Manchester
Dr Ashraf Azzabi
Oncología · Washington
Dr Clare Green
Oncología · Winchester
Dr Desmond Yip
Oncología · Garran